edutainment society by Thanika http://thethanika.blogspot.com/

Guidance for health workers Coronavirus disease (COVID-19) outbreak: rights,roles and responsibilities of health workers, including key considerations for occupational safety and health Health workers are at the front line of the COVID-19 outbreak response and as such are exposed to hazards that put them at risk of infection. Hazards include pathogen exposure, long working hours, psychological distress, fatigue, occupational burnout, stigma, and physical and psychological violence. This document highlights the rights and responsibilities of health workers, including the specific measures needed to protect occupational safety and health. การระบาดของโรค Coronavirus (COVID-19): สิทธิบทบาทและความรับผิดชอบของผู้ปฏิบัติงานด้านสุขภาพรวมถึงการพิจารณาที่สำคัญสำหรับความปลอดภัยและอาชีวอนามัย ผู้ปฏิบัติงานด้านสุขภาพอยู่ในระดับแนวหน้าของการตอบสนองต่อการระบาดของ COVID-19 และเป็นสิ่งที่เสี่ยงต่อการติดเชื้อ อันตรายรวมถึงการสัมผัสกับเชื้อโรค, ชั่วโมงการทำงานที่ยาวนาน, ความทุกข์ทางจิตใจ, ความเหนื่อยล้า,

Coronavirus disease (COVID-19) technical guidance: Points of entry and mass gatherings Questions and answers on mass gatherings and COVID-19 Q&A on Mass Gatherings and COVID-19 Technical Guidance Management of ill travellers at Points of Entry – international airports, seaports and ground crossings – in the context of COVID-19 outbreak This document aims to provide advice on the detection and management of ill travellers suspected of COVID-19 infection, at international airports, ports and ground crossings. It includes the following measures; 1)Detection of ill travellers; 2) Interview of ill travellers for COVID-19; 3) Reporting of alerts of ill travellers with suspected COVID-19 infection and 4) Isolation, initial case management and referral of ill travellers with suspected COVID-19 infection.   -   Access the publication Online course for Management of ill travelers at point of entry This interactive e-learning course is converted from the WHO Interim Guidance for Management of

Coronavirus disease (COVID-19) technical guidance: Guidance for schools, workplaces & institutions Operational considerations for COVID-19 management in the accommodation sector Hotels and tourism accommodation establishments are places where guests stay temporarily in close cohabitation and where there is a high degree of interaction among guests and workers, which requires specific attention in the context of COVID-19. The document offer guidance to collective tourism accommodation establishments such as hotels and similar establishments, holiday and other short-stay accommodation, and campsites. -  Access the publication Preparedness, prevention and control of COVID-19 in prisons and other places of detention Prisons and other places of detention are enclosed environments where people (including staff) live in close proximity. Every country has a responsibility to increase their level of preparedness, alert and response to identify, manage and care for new cases of COVID-19. Cou

Coronavirus disease (COVID-19) technical guidance: Infection prevention and control / WASH Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected This is the first edition of guidance on infection prevention and control (IPC) strategies for use when infection with a novel coronavirus (2019-nCoV) is suspected. It has been adapted from  WHO’s Infection prevention and control during health care for probable or confirmed cases of Middle East respiratory syndrome coronavirus  (MERS-CoV) infection, based on current knowledge of the situation in China and other countries where cases were identified and experiences with severe acute respiratory syndrome (SARS)-CoV and MERS-CoV. - Access the publication Infection Prevention and Control for the safe management of a dead body in the context of COVID-19 This interim guidance is for all those, including managers of health care facilities and mortuaries, religious and public health authorities, and f

Coronavirus disease (COVID-19) technical guidance: Surveillance and case definitions Considerations in the investigation of cases and clusters of COVID-19 This document offers operational guidance to Member States for the rapid investigation of suspected COVID-19 cases after an alert or signal. It is a tool to be used by local, regional, or national health authorities that addresses considerations in investigating cases of COVID-19.  - Access the publication Global Surveillance for human infection with coronavirus disease (COVID-19)  This document provides guidance to Member States on implementation of global surveillance of COVID-19. The objectives of this global surveillance are: to monitor trends of the disease where human to human transmission occurs; rapidly detect new cases in countries where the virus is not circulating; provide epidemiological information to conduct risk assessments at the national, regional and global level; and provide epidemiological information to guide pre

Coronavirus disease (COVID-19) technical guidance: Humanitarian operations, camps and other fragile settings Interim Guidance on Scaling-up COVID-19 Outbreak in Readiness and Response Operations in Camps and Camp-like Settings (jointly developed by IFRC, IOM, UNHCR and WHO) People affected by humanitarian crises, particularly those displaced and/or living in camps and camp-like settings, are often faced with specific challenges and vulnerabilities that must be taken into consideration when planning for readiness and response operations for the COVID-19 outbreak. They are frequently neglected, stigmatized, and may face difficulties in accessing health services that are otherwise available to the general population. In the context of this Interim Guidance, the people in humanitarian situations affected by this guidance may include internally displaced persons (IDPs), host communities, asylum seekers, refugees and returnees, and migrants when in similar situations. While further adaptatio

Virus origin / Reducing animal-human transmission of emerging pathogens Origin of SARS-CoV-2 (26 March 2020) Background The current COVID-19 pandemic is caused by a coronavirus named SARS-CoV-2. Coronaviruses (CoVs) are a large family of viruses, several of which cause respiratory diseases in humans, from the common cold to more rare and serious diseases such as the Severe Acute Respiratory Syndrome (SARS) and the Middle East respiratory syndrome (MERS), both of which have high mortality rates and were detected for the first time in 2003 and 2012, respectively. CoVs are divided into four genera: alpha-, beta-, gamma- and delta-CoV. All CoVs currently known to cause disease in humans belong to the alpha- or the beta-CoV. Many of these CoVs can infect several animal species as well. SARS-CoV infected civet cats and infected humans in 2002 and MERS-CoV is found in dromedary camels and infected humans in 2012. A virus that is regularly transmitted from an animal to a human is called a zoon

Coronavirus disease (COVID-19) technical guidance: COVID-19 Critical Items In response to unprecedented demand and severe disruptions to the global supply chain, the Supply Chain Inter-Agency Coordination Cell (SCICC) has established a supply working group to streamline procurement of critical items facing  global shortage . Procurement of the below critical items is centralized, with transactions undertaken by a restricted group of inter-agency buyers operating at global level in response to country demand. The list is subject to continual review and will be updated accordingly. Requests for supply of the below items must be consolidated at country level through COVID-19 coordination mechanisms (varies per country). Please note:  Until further notice, due to the current evolution of the pandemic and the threat to health system functioning around clinical care, priority for PPE provision is given to health care workers treating critical and severe COVID-19 patients only.

Coronavirus disease (COVID-19) technical guidance: Patient management Clinical management of severe acute respiratory infection when COVID-19 is suspected This document is intended for clinicians taking care of hospitalised adult and paediatric patients with severe acute respiratory infection (SARI) when a nCoV infection is suspected. It is not meant to replace clinical judgment or specialist consultation but rather to strengthen clinical management of these patients and provide to up-to-date guidance. Best practices for SARI including IPC and optimized supportive care for severely ill patients are essential.   -  Access the document Severe Acute Respiratory Infections Treatment Centre  Practical manual to set up and manage a SARI treatment centre and a SARI screening - Access the publication  Considerations for quarantine of individuals in the context of containment for coronavirus disease (COVID-19) The purpose of this document is to offer guidance to Membe

Coronavirus disease (COVID-19) technical guidance: Country readiness Draft operational planning guidance for UN country teams The purpose of this document is to provide a practical guide for the UNCTs and partners to develop a CPRP to immediately support national governments to prepare for and respond to COVID‑19. The initial CPRP should be developed for a 3-month period from 1 February to 30 April in alignment with the SPRP. Subsequent CPRPs will be developed based on the evolving situation and needs. This guide outlines the priority steps and actions to be included in the CPRP across the major areas of the public health preparedness and response. Access the guidance COVID-19 Partners Platform based on Operational Planning Guidance Training modules: Operational Planning Guidelines and COVID-19 Partners Platform National capacities review tool for a novel coronavirus The main aim of the national capacities review tool is to better understand existing capacities in

Coronavirus disease (COVID-19) technical guidance: Maintaining Essential Health Services and Systems COVID-19: Operational guidance for maintaining essential health services during an outbreak When health systems are overwhelmed, both direct mortality from an outbreak and indirect mortality from vaccine-preventable and treatable conditions increase dramatically. Countries will need to make difficult decisions to balance the demands of responding directly to COVID-19, while simultaneously engaging in strategic planning and coordinated action to maintain essential health service delivery, mitigating the risk of system collapse. This document expands on the content of the  Operational planning guidelines to support country preparedness and response , and provides guidance on a set of targeted immediate actions that countries should consider at national, regional, and local level to reorganize and maintain access to high-quality essential health services for all. - Access the publi

Naming the coronavirus disease (COVID-19) and the virus that causes it Official names have been announced for the virus responsible for COVID-19 (previously known as “2019 novel coronavirus”) and the disease it causes.  The official names are: Disease  coronavirus disease  (COVID-19) Virus  severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Why do the virus and the disease have different names?  Viruses, and the diseases they cause, often have different names.  For example, HIV is the virus that causes AIDS.  People often know the name of a disease, but not the name of the virus that causes it. There are different processes, and purposes, for naming viruses and diseases. Viruses are named based on their genetic structure to facilitate the development of diagnostic tests, vaccines and medicines. Virologists and the wider scientific community do this work, so viruses are named by the  International Committee on Taxonomy of Viruses  (ICTV).   Dis